to say it that way—what looks like background to a radiologist can be tomorrow’s terrain to a model.³ The same logic leapt from breasts to lungs. A sibling system, Sybil, reads a single low-dose CT and forecasts lung-cancer risk for up to six years—useful precisely because many scans show nothing yet.⁴ On the other side of the country, a different alarm is getting earlier. A CT hits the server in Sacramento and, before a human sees it, software pings a neurologist’s phone: possible large-vessel stroke. “Time is a major determining factor in outcomes… the AI will help to prioritize cases,” says Dr.
Kwan Ng at UC Davis.⁵ “Being able to make decisions quickly… ensures the best care.” The point isn’t magic; it’s minutes. The FDA now says more than a thousand AI-enabled devices have cleared its pathways—a wave with radiology still in the engine room.¹² Primary care is getting its own shortcuts. In 2018, the first autonomous diagnostic AI ever cleared by the FDA—IDx-DR—let a family clinic detect diabetic retinopathy in minutes, no ophthalmologist on site.⁶ Inside the endoscopy suite, a computer-aided system boxes tiny flickers of mucosa that slip past the human eye. In a randomized trial, adenoma detection jumped from ~40% to ~55% without lengthening the exam.⁷ On the pathology bench, Paige Prostate became the first FDA-authorized AI in digital pathology, flagging coordinates on whole-slide biopsy images so the pathologist’s eye goes straight to the likeliest trouble.⁸ Reality check.
When auditors cracked open a widely used sepsis-prediction model embedded in EHRs, the system missed most cases and flooded clinicians with false alarms—triage upside down.⁹ And bias isn’t a metaphor. One hospital algorithm used cost as a proxy for need; because Black patients historically receive less costly care, the math quietly offered them less help.¹⁰ There are flameouts, too. IBM’s vaunted Watson for Oncology recommended “unsafe and incorrect” treatments, forcing a retreat to humbler goals.¹¹ Still, some bets age well. In 2020, an MIT–McMaster team used deep learning to surface an antibiotic, halicin, that killed drug-resistant pathogens in mice—a hint that AI might not only read biology but write it.¹³ If you want the human end of all this, it is as small as a woman in Sussex who got the all-clear from two radiologists—and then an AI extra reader found what eyes had missed.
“ I just feel so lucky, ” said Sheila Tooth after a quick surgery and no chemo.¹⁴ Back in Worcester, the IV bags are still amber in the late-day light. Nancy watches hers climb and empties the last of her tea. The future is not a promise; it’s a nudge. When it works, what AI buys you is time—and the chance to spend it.
— Chicago-Style Numbered Bibliography 1.